HYPERTENSION DIAGNOSTICS INC (HDII) [Rocket]

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Jun-30-12	Jun-30-11	Jun-30-10	Sep-18-09	Jun-30-09
	10-K	10-K	10-K	10-K/A	10-K/A	10-K	10-K	10-K
Revenues [+]	3.8	3.7	3.6	0.0	0.0	1,383.7		0.5
Royalties				0.0
Products	3.7	3.6	3.4
Revenue growth	3.1%	3.1%			-100.0%	274887.6%		-99.9%
Cost of goods sold [+]	5.7	5.9	6.0	3.2	0.0	194.3		0.3
Cost of product sales				-3.3
Other cost of sales	2.8	2.9	3.0					0.1
Gross profit	-1.9	-2.2	-2.5	-3.2	0.0	1,189.4		0.2
Gross margin	-49.7%	-59.1%	-69.1%	-15573.6%		86.0%		43.4%
Selling, general and administrative	0.9	1.0	1.0	1.2	0.4	2,402.8		0.6
Other operating expenses	-2.7	-2.8	-2.9	-3.1		-214.2
EBITDA [+]	-0.1	-0.4	-0.6	-1.3		-996.8		-0.3
EBITDA growth	-66.4%	-40.1%		242.7%	-100.0%	394763.6%		-100.0%
EBITDA margin	-3.3%	-10.1%	-17.4%	-6143.0%		-72.0%		-50.2%
Depreciation and amortization	0.0	0.0	0.0	0.1		2.4		0.0
EBIT [+]	-0.2	-0.4	-0.7	-1.4	-0.4	-999.2		-0.3
EBIT growth	-60.1%	-38.5%		272.0%	-100.0%	381868.7%		-100.0%
EBIT margin	-4.2%	-11.0%	-18.4%	-6668.4%		-72.2%		-52.0%
Interest income, net [+]	-0.1	-0.1	-0.1	0.0	0.0	9.4		0.0
Interest expense	0.2	0.2	0.2	-0.1
Interest income	0.0	0.0	0.0	0.0	0.0	9.4		0.0
Other income (expense), net	0.2	0.2	0.2	1.2	0.4
Pre-tax income	-0.1	-0.4	-0.6	0.0	0.0	-989.8		-0.2
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0		0.0
Tax rate	0.0%	0.0%	0.0%			0.0%		0.0%
Net income	-0.1	-0.4	-0.6	0.0	0.0	-989.8		-0.2
Net margin	-3.3%	-10.0%	-17.4%	0.0%		-71.5%		-49.4%

Basic EPS [+]				$0.00	$0.00	($23.98)		($0.01)
Growth					-100.0%	392926.4%
Diluted EPS [+]				$0.00	$0.00	($23.98)		($0.01)
Growth					-100.0%	392926.4%

Shares outstanding (basic) [+]				46.8	42.6	41.3		40.7
Growth				9.8%	3.3%	1.4%		-99.9%
Shares outstanding (diluted) [+]				54.2	50.0	41.3		40.7
Growth				8.3%	21.1%	1.4%		-99.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.